New technologies for rapidly identifying pathogens have already entered clinical practice, and will continue to do so into the foreseeable future. Which of these methods will prove to have the most impact on patient outcomes, and will they collectively make traditional culture methods obsolete?
FDA has proposed tough new standards for blood glucose meters that, for the first time, set a higher bar for meters used in hospitals than those intended for lay users.
Despite being the gold standard for diagnosing acute myocardial infarction, confusion remains among clinicians and laboratorians about the timing, frequency, and duration for measuring cardiac troponin.
Download the entire issue
The Latest in Alzheimer’s Disease TestingA New Paradigm for Lab Reimbursement